SCHEMBL6854510

SCHEMBL6854510

COc1n[c]cnc1NS(=O)(=O)c1cccc(Cl)c1Cl

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 20/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1731222 0.84 CCR4 (1.00) CCR4
SCHEMBL29369177 0.84 CCR4 (1.00) CCR4
SCHEMBL1732492 0.81 CCR4 (1.00) CCR4
SCHEMBL6848031 0.80 CCR4 (0.80) CCR4
SCHEMBL1731814 0.80 CCR4 (1.00) CCR4
SCHEMBL1732807 0.80 CCR4 (0.83) CCR4
SCHEMBL1732317 0.79 CCR4 (1.00) CCR4
SCHEMBL1972204 0.79 CCR4 (0.79) CCR4
SCHEMBL6848036 0.79 CCR4 (0.79) CCR4
SCHEMBL1732805 0.79 CCR4 (1.00) CCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1467976-A1 N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES AstraZeneca AB (SE) 2004-10-20 EP disclosed
WO-2003059893-A1 N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES ASTRAZENECA AB (SE) 2003-07-24 WO disclosed